NEUN Stock: Neurogenesis, Inc. Stock Price, Analysis & Insights
Get live NEUN stock price $0.00, comprehensive Neurogenesis, Inc. stock analysis, charts, news, and expert forecast. Real-time NEUN stock data and investment insights.
Loading chart data...
Neurogenesis, Inc. (NEUN) Overview
Neurogenesis, Inc. (NEUN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, NEUN trades at $0.00 with a market capitalization of 8.23K . Over the past 52 weeks, NEUN has traded between $0.00 and $0.00 , with the current price positioned at approximately NaN% of this range . The st...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 8.23K
- Current price: $0.00
- 52-week range: $0.00 - $0.00
- P/E ratio: 17.92
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating primarily within the United States, Neurogenesis, Inc. specializes in the production and distribution of dietary supplements. Its product line includes: NeuBecalm'd: Designed to alleviate the impact of both acute and chronic stress factors....
Company Information
- CEO
- Tal Gilat
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 24
Contact Information
- Website
- https://www.neurogenesis.com
- Address
- 1241 Butler Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -17.40) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Neurogenesis, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Neurogenesis, Inc.
- ⚠Investors should consider how Neurogenesis, Inc. fits within their overall portfolio allocation
Market Cap
8.23K
Beta
-17.40
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NEUN with peer companies:
- Price
- $0.00
- Market cap
- 9.79K
- Price
- $0.00
- Market cap
- 6.53K
- Price
- $0.00
- Market cap
- 18.66K
- Price
- $0.00
- Market cap
- 8.18K
- Price
- $0.00
- Market cap
- 8.20K
- Price
- $0.00
- Market cap
- 67.73K
- Price
- $0.00
- Market cap
- 7.31K
- Price
- $0.00
- Market cap
- 2.49K
- Price
- $0.00
- Market cap
- 7.77K
- Price
- $0.00
- Market cap
- 6.76K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.